Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TERAZOSIN | 10MG | TABLET | Actual shortage | 2017-03-13 | 2020-02-13 | 1619 |
| TEVA-TERAZOSIN | 1MG | TABLET | Actual shortage | 2017-03-13 | 2020-02-13 | 1635 |
| TEVA-TERAZOSIN | 5MG | TABLET | Resolved | 2017-03-13 | 2025-06-17 | 1643 |
| TEVA-TERAZOSIN | 2MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103776 |
| TEVA-TERBINAFINE | 250MG | TABLET | Actual shortage | 2017-03-13 | 2020-02-13 | 1655 |
| TEVA-TERIFLUNOMIDE | 14MG | TABLET | Actual shortage | 2025-10-10 | 2025-12-12 | 269214 |
| TEVA-TERIFLUNOMIDE | 14MG | TABLET | Actual shortage | 2025-11-20 | 2025-12-04 | 272313 |
| TEVA-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2022-10-28 | 2022-12-15 | 173004 |
| TEVA-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2025-07-10 | 2025-07-18 | 262492 |
| TEVA-TIAPROFENIC ACID | 300MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104350 |
| TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2021-11-18 | 2022-02-17 | 149612 |
| TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2023-07-20 | 2023-10-05 | 199360 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2017-05-23 | 2018-07-30 | 10911 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-01-17 | 2020-02-07 | 103593 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-02-21 | 2020-03-26 | 106942 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2021-10-14 | 2021-12-17 | 147231 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2022-07-25 | 2022-12-08 | 165447 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2023-06-08 | 2023-06-21 | 194160 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Actual shortage | 2024-05-09 | 2025-12-11 | 227495 |
| TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2019-08-22 | 2021-08-05 | 92218 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |